In response to AngII, MIAT acts as a molecular sponge of miR-93 which participates in the inactivation of the PI3K/Akt/mTOR pathway via targeting TLR4 in AngII-induced cardiac hypertrophy. The gene discussed is MTOR; the disease is cardiac hypertrophy.